These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 406478)
1. [Synergistic therapeutic effect of adriamycin with 5-fluor-uracil, with prednisolon and with cyclophosphamide on chemically induced mammary cancer of the rat (author's transl)]. Fiebig HH; Schmähl D Klin Wochenschr; 1977 May; 55(9):445-50. PubMed ID: 406478 [No Abstract] [Full Text] [Related]
2. Endocrine and cytostatic treatment of experimental mammary cancer. Fiebig HH; Schmähl D Recent Results Cancer Res; 1980; 71():80-95. PubMed ID: 6768114 [No Abstract] [Full Text] [Related]
3. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)]. Michlmayr G; Kratzer H; Denz H; Huber H Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697 [TBL] [Abstract][Full Text] [Related]
4. [Anti-tumor effects of adriamycin, 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on rat mammary cancer induced by 7,12-dimethyl benz (A) anthracene]. Tominaga T; Kitamura M; Yoshida Y; Kosaki G Gan To Kagaku Ryoho; 1984 Aug; 11(8):1663-8. PubMed ID: 6433800 [TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone]. Raevskiĭ IG Sov Med; 1976 Aug; (8):112-4. PubMed ID: 1006408 [No Abstract] [Full Text] [Related]
6. The effect of ovariectomy, tamoxifen and the combination adriamycin and 5-FU on 7,12-dimethylbenz(a)anthracene induced mammary cancer of the rat. Fiebig HH; Schmähl D Oncology; 1977; 34(2):58-61. PubMed ID: 408773 [No Abstract] [Full Text] [Related]
7. A pilot study of sequential combination chemotherapy with adriamycin and cyclophosphamide, and methotrexate, 5-fluorouracil and prednisolone in advanced breast cancer. Collis CH Br J Clin Pract; 1978 May; 32(5):139-44. PubMed ID: 666968 [No Abstract] [Full Text] [Related]
8. Rationale for adjuvant chemotherapy. Schabel FM Cancer; 1977 Jun; 39(6 Suppl):2875-82. PubMed ID: 141322 [No Abstract] [Full Text] [Related]
9. Inhibitory effect of levamisole and adriamycin on rat mammary cancer induced by 7,12-dimethylbenz(a)anthracene. Tominaga T; Kitamura M; Saito T; Itoh I Eur J Cancer (1965); 1980 Nov; 16(11):1489-93. PubMed ID: 6785092 [No Abstract] [Full Text] [Related]
10. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project. Smalley RV; Carpenter J; Bartolucci A; Vogel C; Krauss S Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy against human melanoma in the hamster cheek pouch. Dufour FD; Okada GT; Mah SG; Morton DL J Surg Oncol; 1980; 15(4):355-61. PubMed ID: 7453185 [TBL] [Abstract][Full Text] [Related]
12. Adriamycin alone or in combination in 100 patients with carcinoma of the cervix or vagina. Piver MS; Barlow JJ; Xynos FP Am J Obstet Gynecol; 1978 Jun; 131(3):311-3. PubMed ID: 78671 [TBL] [Abstract][Full Text] [Related]
13. [Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems (author's transl)]. Nowak C; Arnold W; Henneberger G; Tanneberger S Arch Geschwulstforsch; 1980; 50(8):747-57. PubMed ID: 7224818 [TBL] [Abstract][Full Text] [Related]
14. Interaction between human lymphoblastoid interferon and chemotherapeutic agents in vitro. Takahashi I; Oda Y; Lai M; Fukumoto M; Nishimura M; Yorimitsu S; Kitajima K; Kimura I Acta Med Okayama; 1984 Dec; 38(6):501-4. PubMed ID: 6335349 [TBL] [Abstract][Full Text] [Related]
15. [Therapeutic results of patients with osteogenic sarcoma by the protocol COSS 77 (author's transl)]. Prindull G; Poppe H; Jentsch E; Schauer A Unfallheilkunde; 1981 Dec; 84(12):524-5. PubMed ID: 6948465 [No Abstract] [Full Text] [Related]
16. [Chemotherapy of multiple bone myeloma. Historical and present day aspects. (Second part) (author's transl)]. Bataille R; Morlock G; Rosenberg F; Sany J; Serre H Sem Hop; 1979 Sep 18-25; 55(31-32):1377-82. PubMed ID: 228415 [TBL] [Abstract][Full Text] [Related]
17. [Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)]. Castor H; Fritsch H; Drings P; Moskwa G; von Kaick G Med Klin; 1974 Apr; 69(17):750-6. PubMed ID: 4837493 [No Abstract] [Full Text] [Related]
18. [Efficiency and side effects of adriamycin-cyclophosphamide therapy compared to a triple combination of cyclophosphamide, methotrexate and 5-fluoro-uracil]. Weymar P; Schulz KD; Noldus B; Schmidt-Rhode P Arch Gynecol; 1979 Jul; 228(1-4):445-6. PubMed ID: 485425 [No Abstract] [Full Text] [Related]
19. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma. Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D Anticancer Res; 1998; 18(4A):2567-73. PubMed ID: 9703911 [TBL] [Abstract][Full Text] [Related]
20. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer. De Lena M; Brambilla C; Morabito A; Bonadonna G Cancer; 1975 Apr; 35(4):1108-15. PubMed ID: 1116104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]